MetLife
1,401 hedge funds and large institutions have $41.6B invested in MetLife in 2024 Q4 according to their latest regulatory filings, with 187 funds opening new positions, 496 increasing their positions, 506 reducing their positions, and 76 closing their positions.
146% more first-time investments, than exits
New positions opened: 187 | Existing positions closed: 76
7% more funds holding
Funds holding: 1,315 → 1,401 (+86)
0.19% more ownership
Funds ownership: 72.75% → 72.94% (+0.19%)
1% less capital invested
Capital invested by funds: $42B → $41.6B (-$414M)
2% less repeat investments, than reductions
Existing positions increased: 496 | Existing positions reduced: 506
14% less funds holding in top 10
Funds holding in top 10: 14 → 12 (-2)
39% less call options, than puts
Call options by funds: $683M | Put options by funds: $1.12B
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$517M |
| 2 |
Bank of New York Mellon
New York
|
+$383M |
| 3 |
ClearBridge Investments
New York
|
+$143M |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
+$127M |
| 5 |
Swedbank
Stockholm,
Sweden
|
+$125M |
Top Sellers
MET Hedge Fund Activity: Q4 2024 in Review
1,401 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in MetLife (MET) for Q4 2024, worth a combined $41.6B — down 0.98% from $42B a quarter earlier.
Buyers outnumbered sellers: 187 funds opened new MET positions and 76 closed out — a net gain of 111 holders — while 496 added to existing stakes and 506 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $517M. The largest seller was JP Morgan Chase, cutting an estimated $567M.
- 1,401 institutional investors held MetLife (MET) as of Q4 2024, up from 1,315 in Q3 2024.
- Funds reported $41.6B of MetLife stock for Q4 2024, down 0.98% quarter-over-quarter.
- 187 funds opened new MetLife positions in Q4 2024 and 76 closed out, a net change of +111 holders.
- The largest MetLife buyer in Q4 2024 was T. Rowe Price Associates, an estimated $517M added.
- The largest MetLife seller in Q4 2024 was JP Morgan Chase, an estimated $567M sold.
Based on aggregated 13F filings for Q4 2024.